| Literature DB >> 35068493 |
Prasannan Geetha Preena1, Arathi Dharmaratnam1, Thangaraj Raja Swaminathan1.
Abstract
Edwardsiella tarda is one of the serious threats affecting the worldwide aquaculture. In the present study, four isolates were recovered from diseased goldfish, showing hemorrhages, reported with 60% mass mortality in an ornamental fish farm, Ernakulam, Kerala. Based on the phenotypic and genotypic analysis, the bacteria were identified as Edwardsiella tarda, Citrobacter freundii, Acinetobacter junii and Comammonas testosteronii. Experimental challenge studies using healthy goldfish revealed that among the four isolates, E. tarda alone leads to 100% mortality of experimental fish within 175 degree days and the pathogen could be successfully re-isolated from the moribund fish. The LD50 value of E. tarda was calculated as 9.9 × 105 CFU/fish. The histopathology of the infected tissues of goldfish had shown the typical features of E .tarda infection. The pathogen was found positive for the virulence genes viz., hly, etfA, etfD and eseD as detected using PCR. Thus E. tarda was confirmed as the real causative agent of the disease outbreak. Multiple antimicrobial resistance (AMR) exhibited by the pathogen towards 19 tested antibiotics with the MAR index of 0.46 highlighted the exposure of antibiotics to the fish in the farm. The existence of antibiotic resistant genes within the plasmid as revealed through plasmid curing studies pointed out the possibility of rapid dissemination of AMR in aquaculture. Hence proper surveillance and appropriate diagnostic methods need to be implemented at regular intervals to mitigate the menace. © Institute of Molecular Biology, Slovak Academy of Sciences 2022.Entities:
Keywords: Antimicrobial resistance; Aquaculture; Edwardsiella tarda; Goldfish; Virulence
Year: 2022 PMID: 35068493 PMCID: PMC8764882 DOI: 10.1007/s11756-022-01007-9
Source DB: PubMed Journal: Biologia (Bratisl) ISSN: 0006-3088 Impact factor: 1.653
Fig. 1The geographic map showing the fish sampling site
Oligonucleotide primers for the detection of virulence genes and species specific gene of Edwardsiella tarda
| Sl.no. | Gene name | Primer sequences (5'-3') | PCR amplification conditions |
|---|---|---|---|
| Virulent Genes | |||
| 1. Hemagglutinating fimbrial protein encoding genes | |||
| 1. | CGG TAAAGTTGAGTT TACGGGTG | initial denaturation: 94°C/ 5 min 30 cycles of denaturation 94 °C/ 1 min annealing 55 °C /1 min, extension 72 °C/1 min final extension 72 °C /10min | |
TGTAACCGT GTT GGC GTAAG | |||
| 2. | GGTAACCTG ATTTGGCGTTC | ||
GGATCACCT GGATCTTAT CC | |||
| 2. Hemolysin gene | |||
| 3 | AACAAGGATAAGCACTGTTCTGGCT CCATATAAGCGGTCAATCCCGTCA | initial denaturation: 94°C/ 5 min 30 cycles of denaturation 94 °C/ 1 min annealing 60 °C /1 min, extension 72 °C/1 min final extension 72 °C /10min | |
| 3. Enterohemolysin gene | |||
| 4 | GGTGCAGCAGAAAAAGTTGTAG TCTCGCCTGATAGTGTTTGGTA | initial denaturation: 94°C/ 5 min 35 cycles of denaturation 94 °C/ 1 min annealing 58 °C -62°C /1 min, extension 72 °C/1 min final extension 72 °C /10min | |
| 4. Type III secretion system protein encoding genes (TTSS) | |||
| 5 | CTACGACAACAACCTGGATCGTCGCAT | initial denaturation: 94°C/ 5 min 35 cycles of denaturation 94 °C/ 1 min annealing 56 °C /1 min, extension 72 °C/1 min final extension 72 °C /10min | |
GTCGATCTGATTAGCCACCTGCTG | |||
| 6 | GGATCACGATCCTAAGCG | ||
CTTGGCCGACATTTCGAC | |||
| 7 | GGACGGCCATCGTTACGTTTCAC | ||
TTTCCAGCGTTTCATCCG | |||
| 8 | TATGCCTGCCAGGTCCGC | ||
CCTCGATATTGAGGATCAGCAAT | |||
| 9 | GATCTCGCTACGCTGCATGGT | ||
GCCAGCAGCAGGTAAAAGCGT | |||
| 10 | IF GGAGTAAGCCTTATCGCAG IR CGTCAGGCGCTGCATAATG | ||
| 11 | GATCATGCCTTGCTAGCC TCGGCGACCAGCTTGAGA | ||
| Species specific gene for | |||
| 12 | CCT TAT AAA TTA CTC GCT TTT GTG GAG TAA CAG TTT | initial denaturation: 94°C/ 5 min 35 cycles of denaturation 94 °C/ 1 min annealing 55 °C /1 min, extension 72 °C/1 min final extension 72 °C /10min | |
Antibiotic resistance pattern of E.tarda NPET-1 before and after plasmid curing
| Antibiotics | Antibiotic resistance pattern of | |
|---|---|---|
| Minimum inhibitory concentration of resistant antibiotics (mcg/ml) | ||
| Before plasmid curing | After plasmid curing | |
| β-Lactams | ||
| Amoxicillin (0.016-256mcg/ml) | >256 | >256 |
| Amoxyclav (0.016-256mcg/ml) | NR | NR |
| Ampicillin (0.016-256mcg/ml) | >256 | >256 |
| Aztreonam (0.016-256mcg/ml) | >256 | NR |
| Piperacillin/Tazobactam (0.016-256mcg/ml) | NR | NR |
| First generation cephalosporins | ||
| Cefalexin (0.016-256mcg/ml) | NR | NR |
| Cefazolin (0.016-256mcg/ml) | NR | NR |
| Cefuroxime (0.016-256mcg/ml) | NR | NR |
| Cephalothin (0.016-256mcg/ml) | >256 | |
| Second generation cephalosporins | ||
| Cefoxitin (0.016-256mcg/ml) | >256 | NR |
| Third generation cephalosporins | ||
| Cefixime/Clavulanic acid (0.016-256mcg/ml) | NR | NR |
| Cefoperazone (0.016-256mcg/ml) | >256 | NR |
| Cefotaxime (0.016-256mcg/ml) | NR | NR |
| Ceftazidime (0.016-256mcg/ml) | >256 | |
| Ceftriaxone (0.016-256mcg/ml) | NR | NR |
| Fourth generation cephalosporins | ||
| Cefepime (0.016-256mcg/ml | NR | NR |
| Carbapenem | ||
| Doripenem(0.002-32mcg/ml) | NR | NR |
| Imipenem (0.002-32mcg/ml) | NR | NR |
| Meropenem (0.002-32mcg/ml) | NR | NR |
| Aminoglycosides | ||
| Gentamycin (0.064-1024mcg/ml) | >1024 | NR |
| Streptomycin (0.016-256mcg/ml) | >256 | NR |
| Tobramycin (0.016-256mcg/ml) | 128 | NR |
| Phenicols | ||
| Chloramphenicol (0.016-256mcg/ml) | >256 | |
| Quinolones and Fluoroquinolones | ||
| Ciprofloxacin (0.016-256mcg/ml) | NR | NR |
| Enrofloxacin (0.002-32mncg/ml) | NR | NR |
| Nalidixic acid (0.016-256mcg/ml) | NR | NR |
| Norfloxacin (0.016-256mcg/ml) | NR | NR |
| Perfloxacin (0.016-256mcg/ml) | NR | NR |
| Tetracyclines | ||
| Tetracycline (0.016-256mcg/ml) | >256 | NR |
| Macrolides | ||
| Azithromycin (0.016-256mcg/ml) | 64 | NR |
| Erythromycin (0.016-256mcg/ml) | NR | NR |
| Sulphonamides | ||
| Co-trimoxazole (0.016-256mcg/ml) | ||
| Sulphadiazine (0.016-256mcg/ml) | 128 | NR |
| Trimethoprim (0.016-256mcg/ml) | 128 | NR |
| Nitrofurans | ||
| Furazolidone (0.016-256mcg/ml) | NR | NR |
| Nitrofurantoin (0.032-512 mcg/ml) | NR | NR |
| Glycopeptides | ||
| Bacitracin (0.016-256mcg/ml) | >256 | NR |
| Vancomycin (0.016-256mcg/ml) | >256 | NR |
| Other antibiotics | ||
| Colistin (0.016-256mcg/ml) | 128 | 128 |
| Polymyxin-B (0.016-256mcg/ml) | NR | NR |
| Rifampicin (0.002-32mcg/ml) | >256 | NR |
NR- Not Resistant
Fig. 2Phylogenetic analysis of 16 S rRNA gene sequences of Edwardsiella tarda strain NPET-1 showing relationship with other reported strains of Edwardsiella. The tree was constructed by MEGA X using Neighbour-joining method
Fig. 3Clinical signs showing hemorrhages on the external and internal body part of (a) infected goldfish (b) experimentally challenged goldfish
Fig. 4Histopathological changes in (A) Kidney: Thick arrow: tubular degeneration & necrosis; Arrowhead: interstitial nephritis; Thin arrow: rupture of basement membrane (B) Liver: Thick arrow: multifocal areas of necrosis of the hepatic parenchyma; Thin arrow: vacuolar degeneration; Star: Increased activity of kupffer cells; arrowhead: sinusoidal dilatation (C) Spleen: Arrow: Multifocal areas of lymphocytolysis of the spleen
Fig. 5Gel pictures showing the amplification of virulence genes viz. etfA, etfD, eseD and hly and species specific tarda gene with 100 bp DNA ladder